201results about How to "Solve discoloration" patented technology

The actinidia arguta is a specific precious wild resource. The meat of the actinidia arguta is jade green; the actinidia arguta tastes fine, juicy, fragrant and delicious; the sweetness and the sourness are proper; the nutrition is very rich; the actinidia arguta is a fruit well received by customers and is known as the king of fruits. Wild actinidia arguta resources are readily available in Changbai Mountains, but products of the actinidia arguta are few and cannot meet the consumption demands in different seasons, so that the demands of the customers for wild actinidia arguta products are suppressed. The invention discloses a preparation technology for Changbai-mountain pure natural wild actinidia arguta fruit powder. According to the technology, the freeze-dried fruit powder is prepared by selecting fresh and intact actinidia arguta, washing, smashing, pulping and concentrating the actinidia arguta, adding maltodextrin and performing vacuum freeze-drying on mixed fruit paste. The actinidia arguta freeze-dried fruit powder is high in nutrient value and is convenient food suitable for various groups of people.

The invention relates to a method for preparing zinc molybdate ultrafine anti-bacterial powder by adopting a molten-salt growth method. The method comprises the following steps that: sodium molybdate and zinc nitrate serving as raw materials and sodium nitrate serving as a salt material are mixed in a mortar in the proportion of 1:1:8-18; a proper amount of absolute alcohol is added in the mortar to grind for 1 to 2 hours to ensure that the raw materials and the salt material are mixed sufficiently and uniformly; the mixture is dried for 2 to 4 hours at 90 DEG C in a crucible, and is melted and calcined for 3 to 7 hours in an electric furnace at the temperature of between 320 and 360 DEG C; and the calcined curing product is sufficiently soaked and washed with distilled water, is filtered and dried to remove residual fused salt to obtain the ultrafine zinc molybdate powder. Researches prove that the ultrafine zinc molybdate anti-bacterial powder prepared by the molten-salt growth method has bacteria resistance superior to the anti-bacterial powder synthesized by a chemical precipitation method under the same testing condition, and avoids the problems of high cost and color change by using a silver antibacterial agent. The method can be widely applied in the fields of plastics, ceramics, paints and the like.

The invention relates to a stable and safe oxiracetam pharmaceutical composition for injection and a preparation method thereof, especially to an oxiracetam pharmaceutical composition for treating brain damage and neurological deficit caused by the brain damage as well as impediment of anamnesis and aptitude. Preferred are injections and lyophilized powders. The oxiracetam pharmaceutical composition provided by the invention mainly contains active components of oxiracetam, sodium chloride and citric acid. The oxiracetam pharmaceutical composition for injection has stable pH values and low impurity content. By the adoption of the preparation method, curative effects of the product are effectively raised, side effects are minimized, and simultaneously the yield is raised, cost is reduced, and higher benefits are created.

In order to overcome the problems of insufficient high-temperature cycle performance and battery expansion of an existing lithium ion battery, the invention provides a non-aqueous electrolytic solution, which comprises a solvent, an electrolyte salt and an additive, wherein the additive comprises unsaturated phosphate shown in a structural formula 1, bicyclic carbonate shown in a structural formula 2 and cyclic sulfate shown in a structural formula 3. The invention also discloses a lithium ion battery comprising the non-aqueous electrolytic solution. When the non-aqueous electrolytic solutionprovided by the invention is applied to the lithium ion battery, the non-aqueous electrolytic solution has relatively good long-term high-temperature cycle performance and long-term high-temperature storage performance and relatively low volume expansion rate, and the electrolytic solution has relatively good stability in long-term circulation.

The invention discloses a special primer-topcoat polyurea protection coating for an automobile chassis system and a preparation method. The coating is prepared from a component A and a component B in a volume ratio of 1:(2-4), wherein the component A comprises isocyanate, a poly-sulfide modified epoxy resin and a diluent; the component B comprises an aliphatic synthetic hindered amine polyurea resin, a coloring pigment, a filler, graphene pulp, organic zinc, a dispersing agent, an ultraviolet absorbent, an ultraviolet light stabilizer, an anti-settling agent, a leveling agent, a defoaming agent, extinction powder and a dissolvent. The invention further discloses a preparation method of the special primer-topcoat polyurea protection coating for the automobile chassis system. The thickness of a disposable coating membrane is greater than or equal to 80mu m, a coating membrane is rapid in drying speed and high in construction efficiency, a coated layer is good in adhesion to a substrate, good in impact resistance, free of color change in long-term outdoor exposure, very good in aging resistance, salt mist resistance and medium resistance, high in product solid content and good in environmental friendliness, and the method provided by the invention is simple in process, low in cost and applicable to industrial production.

The present invention provides a preparation method of stilbite carrier zinc series in organic antimicrobial agent. Said invented inorganic antibacterial agent is not limited by physical environment, has strong antibacterial action, good persistent availability, broad-spectrum antibacterial property and good compatibility for making other products. It can solve the product discoloration problem due to addition of antimicrobial agent, can raise the fineness of inorganic antimicrobial agent powder body, and can be uniformly distributed in the product, at the same time it can greatly reduce cost of inorganic antimicrobial agent.

The invention provides niclosamide ethanolamine salt wettable powder as well as a preparation method and application thereof. The wettable powder is prepared from niclosamide ethanolamine salt, a dispersing and wetting agent, a suspension aid and an anti-caking agent, wherein the dispersing and wetting agent is a compound mixture of fatty alcohol-polyoxyethylene ether and a non-ionic hydroxyl polyethylene oxide block copolymer, and the use amount of the dispersing and wetting agent accounts for 8-15% of the total weight of the raw materials. By using the compound mixture of the fatty alcohol-polyoxyethylene ether and the non-ionic hydroxyl polyethylene oxide block copolymer as the dispersing and wetting agent, a unique steric hindrance effect is provided in the system, so that the stability of the system is effectively kept and the problems of slow wetting, color change and flocculation are solved; the wettable powder is short in wetting time, uniform in dispersion effect, relatively small in particle size distribution, capable of rapidly reaching a target site, free from flocculation for a long time and free from particle aggregation, so that the wettable powder has long-lasting efficacy and applicable to hard water. The wettable powder disclosed by the invention is applicable to the preparation of molluscicidal products and is good in molluscicidal effect.

The invention relates to a pharmaceutical composition of omeprazole sodium, and a preparation method of the pharmaceutical composition. The pharmaceutical composition of omeprazole sodium comprises the following raw materials by weight: 40-60 parts of omeprazole sodium, 5-10 parts of sodium chloride, 0.4-0.6 part of disodium edetate, a proper amount of pH regulating agent and 2-3 parts of water for injection; and the amount of omeprazole sodium is calculated in omeprazole. The pharmaceutical composition of omeprazole sodium does not change color, does not generate a cloudy precipitate, and has good stability, and the insoluble particles from the pharmaceutical composition combined with the injection are not obviously increased along with the extension of storage time; and the pharmaceutical composition is of great help to the improvement of output rate of the product, reduction of market risk of the product and better application in clinical treatment.

The invention relates to the technical field of coatings, and particularly relates to a roller coating type simulated face brick coating and a construction method. The roller coating type simulated face brick coating is prepared by dispersing the following components in parts by weight in a dispersing kettle: 10-20 parts of ethylene glycol, 2-6 parts of dispersing agents, 1-2 parts of AMP 95, 50-100 parts of 2% hydroxy ethyl cellulose solutions, 30-50 parts of 10% inorganic gels, 1-2 parts of wetting agents, 3-9 parts of defoaming agents, 500-600 parts of natural rock flour, 50-100 parts of rigid polymer emulsions, 50-100 parts of elastic polymer emulsions, 5-10 parts of film forming auxiliary agents, 5-10 parts of hydrophobic modified alkali swelling thickening type thickening agents, 1-6 parts of hydrophobic modified alkali swelling associating type thickening agents, 1-2 parts of sterilizing agents and 110-240 parts of water. According to the invention, a coated film grain obtained after roller coating is more similar to that of an exterior wall tile.

The invention discloses a canned pear preparing method and belongs to the technical field of canned food processing. The method includes the following technical steps that 1, by weight, 45-60 parts of fresh pears are cleaned, peeled, denucleated and cut into blocks; 2, 2-6 parts of dried honeysuckle, 1-3 parts of liquorice, 1-3 parts of schisandra chinensis, 1-3 parts of shaddock peels are taken, deionized water 10 times of the mixture in weight is added to the mixture, the mixture is continuously decocted for 25-40 minutes after being boiled and then filtered, and the filtered liquid is taken; 3, the preprocessed pears are placed into water at the temperature of 90 DEG C-100 DEG C for precooking for 1-3 minutes, then 0.5-1 part of color fixative is added, the mixture is boiled continuously for 0.5-1 minute, and the pear meat is fished out for cooling; 4, 1-4 parts of mixture of sugar and 60-8- parts of water are added to a cooking pot, and the mixture is cooled to the room temperature after being boiled; 5, canning is conducted, 6, sealing and sterilizing are conducted. The canned pear has the advantages that the canned pears have a certain heal care effect, are good in color and luster and can increase the appetite of eaters.

The invention relates to a torasemide pharmaceutical composition with stabilization and safety for injection and its preparation method, especially relates to the torasemide pharmaceutical composition used for patients with requirement of rapid diuresis or congestive cardiac failure without oral diuresis, cirrhosis ascites, oedema caused by kidney diseases, the torasemide pharmaceutical composition is an injection preferably. The pharmaceutical composition is composed of active component torasemide, ethanol and polysorbate 80. The torasemide pharmaceutical composition for injection possesses stable pH value and low impurity content, and is capable of effectively raising the treatment effect of the products, minimizing the side reaction, raising the yield, reducing the cost and creating higher benefit.

The invention relates to the technical field of photovoltaic glass, and provides glass ink and high-reflection backboard glass. The glass printing ink provided by the invention is composed of powder and an oil agent, wherein the powder comprises glass powder, titanium dioxide and an inorganic reducing agent, and the weight percentage of the inorganic reducing agent in the glass printing ink is 2%-5%. The glass ink is used for forming a high-reflection glaze layer of the high-reflection back plate glass, titanium dioxide in the high-reflection glaze layer is effectively prevented from being oxidized during PID testing by adding an inorganic reducing agent with a specific content into powder; in addition, the problem that the glaze layer of the high-reflection back plate glass changes colorduring PID testing is solved by means of the rutile type titanium dioxide.

The invention aims at providing a lansoprazole lyophilized medicine composition used for injection. According to the invention, lansoprazole is dissolved in a solution of sodium hydroxide and mannitol; the obtained solution is lyophilized, such that the medicine composition is obtained. In the medicine composition, a weight ratio of lansoprazole:mannitol:sodium hydroxide is 2-8.5:2-8.5:1, and preferably 6:6:1. The medicine composition is advantaged in simple formula and small amount of auxiliary materials. Therefore, side effects caused by excess dosages of auxiliary materials are overcome; a lyophilization time is greatly reduced, such that unnecessary energy consumption is saved. Therefore, the lansoprazole medicine composition has certain competitive strength in markets.